These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 18197853

  • 1. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
    Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E.
    J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.
    Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J.
    Int J Oncol; 2005 Mar; 26(3):817-24. PubMed ID: 15703841
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E.
    Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
    [Abstract] [Full Text] [Related]

  • 4. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
    Chang HK, Park J, Kim W, Kim K, Lee M, Park U, Choi B.
    Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
    [Abstract] [Full Text] [Related]

  • 5. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC.
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [Abstract] [Full Text] [Related]

  • 6. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA, Neel HB, Strome SE, Roche P.
    Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
    [Abstract] [Full Text] [Related]

  • 7. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
    Figueiredo DL, Mamede RC, Proto-Siqueira R, Neder L, Silva WA, Zago MA.
    Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S, Kang SH, Ro J, Jeon CH, Park JW, Lee ES.
    Cancer; 2005 Jul 15; 104(2):251-6. PubMed ID: 15937912
    [Abstract] [Full Text] [Related]

  • 10. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.
    Cancer Res; 2002 Jul 15; 62(14):3971-9. PubMed ID: 12124329
    [Abstract] [Full Text] [Related]

  • 11. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.
    Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407
    [Abstract] [Full Text] [Related]

  • 12. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY.
    Arch Oral Biol; 2007 Nov 15; 52(11):1079-87. PubMed ID: 17612501
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
    Shin KC, Choi EY, Chung JH, Jeon C, Lee KH.
    Anticancer Res; 2012 Jan 15; 32(1):163-7. PubMed ID: 22213302
    [Abstract] [Full Text] [Related]

  • 15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, Nishimura T.
    Int J Oncol; 2006 May 15; 28(5):1089-98. PubMed ID: 16596224
    [Abstract] [Full Text] [Related]

  • 16. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
    Mecklenburg I, Weckermann D, Zippelius A, Schoberth A, Petersen S, Prang N, Riethmüller G, Kufer P.
    J Immunol Methods; 2007 Jun 30; 323(2):180-93. PubMed ID: 17540401
    [Abstract] [Full Text] [Related]

  • 17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 30; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 18. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
    Sienel W, Mecklenburg I, Dango S, Ehrhardt P, Kirschbaum A, Passlick B, Pantel K.
    Clin Cancer Res; 2007 Jul 01; 13(13):3840-7. PubMed ID: 17606715
    [Abstract] [Full Text] [Related]

  • 19. Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines.
    Müller-Richter UD, Dowejko A, Zhou W, Reichert TE, Driemel O.
    Oral Oncol; 2008 Jul 01; 44(7):628-33. PubMed ID: 17993289
    [Abstract] [Full Text] [Related]

  • 20. MAGE-A gene expression pattern in primary breast cancer.
    Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Löning T, Jänicke F, Pantel K.
    Cancer Res; 2001 Sep 15; 61(18):6682-7. PubMed ID: 11559535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.